We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

But the deal is a game-changer for the U.S. pharmaceutical scene. Teva could become about the same size as Pfizer (PFE) -- currently the largest drug company by revenues, at $68 billion last year ...

As of 04:00PM EDT. Market open. Teva's reasonable valuation, an improving pipeline and the prospect of growth in sales and profits are good enough reasons for those who own the stock to stay invested.